LMG Life Sciences Awards EMEA 2024: key dates revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2024: key dates revealed

LMG Life Sciences Awards 2024 EMEA _ bkgrd_4x.png

Key dates for the LMG Life Sciences EMEA research for 2024 have been released

The LMG Life Sciences Awards EMEA is excited to announce its return for its fifth year and reveal its key dates for the 2024 research. The Awards will be open for submissions starting December 7.

Please note the following dates in your calendars:

Nominations Open

Nominations Close

Shortlist Published

Gala Ceremony

7 December 2023

25 January 2024

March 2024

May 2024


The life sciences industry will be invited to provide nominations for leading practitioners, firms, cases and deals. The Awards will recognise the most outstanding work completed by private practice law firms, as well as in-house legal teams and counsels during 2023.

If you have any questions about the research, please contact the LMG Life Sciences awards editor, John Harrison.

LMG Life Sciences produces the most respected awards programme for life sciences practitioners and law firms across Europe, the Middle East, and Africa. Honourees are determined through a rigorous research process that aims to recognise and celebrate excellent legal work and client service over a 12-month period.

The awards span four broad practice areas: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement.

In addition to award categories for firms and individuals, an array of unique awards are announced each year to highlight the achievements of in-house teams and to celebrate Impact Cases and Deals of the Year.

Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IP Stars research.

more from across site and SHARED ros bottom lb

More from across our site

The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Ana Castedo, who brings a strong focus on patent litigation, will help build the firm’s IP litigation offering in Madrid
Gift this article